Annual Total Liabilities
$38.37 M
+$3.48 M+9.99%
31 December 2023
Summary:
Viracta Therapeutics annual total liabilities is currently $38.37 million, with the most recent change of +$3.48 million (+9.99%) on 31 December 2023. During the last 3 years, it has risen by +$24.19 million (+170.59%). VIRX annual total liabilities is now -59.40% below its all-time high of $94.50 million, reached on 31 December 2020.VIRX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$28.57 M
-$76.00 K-0.27%
30 September 2024
Summary:
Viracta Therapeutics quarterly total liabilities is currently $28.57 million, with the most recent change of -$76.00 thousand (-0.27%) on 30 September 2024. Over the past year, it has dropped by -$9.80 million (-25.53%). VIRX quarterly total liabilities is now -69.76% below its all-time high of $94.50 million, reached on 31 December 2020.VIRX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIRX Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -25.5% |
| 3 y3 years | +170.6% | +101.5% |
| 5 y5 years | - | - |
VIRX Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +170.6% | -25.5% | +135.2% |
| 5 y | 5 years | -59.4% | +170.6% | -69.8% | +149.2% |
| alltime | all time | -59.4% | +170.6% | -69.8% | +149.2% |
Viracta Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $28.57 M(-0.3%) |
| June 2024 | - | $28.65 M(-5.3%) |
| Mar 2024 | - | $30.25 M(-21.2%) |
| Dec 2023 | $38.37 M(+10.0%) | $38.37 M(+5.3%) |
| Sept 2023 | - | $36.43 M(+1.0%) |
| June 2023 | - | $36.08 M(+4.1%) |
| Mar 2023 | - | $34.67 M(-0.6%) |
| Dec 2022 | $34.89 M | $34.89 M(+142.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $14.39 M(+18.4%) |
| June 2022 | - | $12.15 M(-4.9%) |
| Mar 2022 | - | $12.78 M(-9.9%) |
| Dec 2021 | $14.18 M(-85.0%) | $14.18 M(+12.9%) |
| Sept 2021 | - | $12.56 M(+8.5%) |
| June 2021 | - | $11.58 M(+1.0%) |
| Mar 2021 | - | $11.46 M(-87.9%) |
| Dec 2020 | $94.50 M | $94.50 M |
FAQ
- What is Viracta Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly total liabilities year-on-year change?
What is Viracta Therapeutics annual total liabilities?
The current annual total liabilities of VIRX is $38.37 M
What is the all time high annual total liabilities for Viracta Therapeutics?
Viracta Therapeutics all-time high annual total liabilities is $94.50 M
What is Viracta Therapeutics quarterly total liabilities?
The current quarterly total liabilities of VIRX is $28.57 M
What is the all time high quarterly total liabilities for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly total liabilities is $94.50 M
What is Viracta Therapeutics quarterly total liabilities year-on-year change?
Over the past year, VIRX quarterly total liabilities has changed by -$9.80 M (-25.53%)